Taaleri PLC (FRA:295) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Market …

GuruFocus News

Thu, February 12, 2026 at 12:01 AM GMT+9 3 min read

In this article:

TAALA.HE

-6.93%

295.F

-3.78%

This article first appeared on GuruFocus.

Release Date: February 11, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Continuing earnings grew by 17%, driven mainly by renewable energy and the final close of the Solar Wind Fund.

The disallowance refund achieved a final close with EUR 630 million in investment capacity, with EUR 557 million being fee-generating AUM.

Karantia strengthened its market position, with 1 in 8 housing transactions in Finland utilizing its services.

The insurance service result grew by 8%, supported by a positive investment income of EUR 3 million in the last quarter.

Taaleri PLC (FRA:295) made its first investment aligned with its updated development capital strategy in Rengas, a renewable energy company.

Negative Points

Revenue declined by 13.2% due to a decrease in investment income, reflecting a challenging comparison to the previous year's exceptional results.

Operating profit decreased to EUR 25.9 million, impacted by lower investment income.

The renewable energy segment saw a decline in operating profit from EUR 3.4 million to EUR 2.4 million due to increased costs.

The investment segment's revenue was significantly lower compared to the previous year, reflecting a decline in development portfolio sales.

The biofuel market faced challenges, with weaker demand and price development in the biochemicals segment.

Q & A Highlights

Warning! GuruFocus has detected 4 Warning Signs with FRA:295.

Is FRA:295 fairly valued? Test your thesis with our free DCF calculator.

Q: About the equity share in your portfolio, it has historically been 10 to 15%, now it’s close to 30%. Should we consider this 30% as a new normal? A: (Unidentified_2) In their investment policy, 25% is a neutral position. The increase to almost 30% is due to significant stock market growth, but no major changes are expected as the policy remains the same. Investment professionals optimize allocation based on market opportunities.

Q: Can you provide more detail on the writedown of the bio plant? It seems drastic, cutting the stake in half. What led to this decision? A: (Unidentified_2) The facility faced technical issues during ramp-up, which is common with new technologies. There are energy balance issues requiring additional investments. The writedown reflects financial principles and uncertainty related to additional financing needed for the plant.

Q: Regarding the refinancing of the bio plant, do you need to inject more cash or seek outside equity? A: (Unidentified_2) This is under negotiation, with both external and internal sources being considered. The decision depends on the technical solutions identified.

Story Continues  

Q: About the Rain Gas investment, it was 1.6 million in your balance sheet. Is your stake higher, and will it grow as the company needs capital? A: (Unidentified_3) The investment was a1.5 million, with additional payments tied to certain milestones.

Q: What kind of new funds will be in focus this year, especially in private asset management? A: (Unidentified_2) The target is to initiate Solar Wind IV during the financial year. In bio industry, fundraising will not happen in 2026 but is expected in 2027. Real estate projects are in various phases, and new strategies are planned for 2026-2028.

Q: Do you expect to book any performance fees this year, considering some funds are in the exit phase? A: (Unidentified_2) Performance fees are tested quarterly and recognized accordingly. No forward-looking statements are made, as it depends on fund development.

Q: Can you remind us of the running yield on the guarantee bond portfolio? A: (Unidentified_2) The exact number isn’t available, as it has changed during the year. No specific figures are provided.

Q: Regarding the outlook for the bio industry fundraising, how do you see it given the current market difficulties? A: (Unidentified_2) The bio fund strategy focuses on bio-based or recycled materials, not bioenergy. Despite market challenges, some LPs find it attractive due to current valuations and the need to replace fossil-based materials.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Terms and Privacy Policy

Privacy Dashboard

More Info